Clinical studies recruiting near Brno

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Hav
Phase 3 · Fakultní nemocnice Brno Bohunice · Pfizer · NCT05020236 A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · Masarykuv onkologicky ustav · Eli Lilly and Company · NCT07218380 This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · Fakultni Nemocnice u sv. Anny v Brne · Pfizer · NCT07028853 Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
Phase 3 · University Hospital Brno · Princess Maxima Center for Pediatric Oncology · NCT05327894 Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease
Phase 2/Phase 3 · Local Institution - 0115 · Bristol-Myers Squibb · NCT07106762 Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · Masarykuv onkologicky ustav-Klinika komplexni onkologicke pe · Merck Sharp & Dohme LLC · NCT06393374 A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney Disease
Phase 3 · Site CZ42002 · Astellas Pharma Global Development, Inc. · NCT05970172 Low Serum Creatinine as a Predictor of Prolonged Mechanical Ventilation and Weaning Failure
NA · Chronicare Mund s.r.o. · University Hospital Ostrava · NCT07177183 Clinical Performance of Medical Device Software "Lipidica 1.0" for Processing Data Generated by Lipidomic Analysis in Pa
NA · Fakultni nemocnice Brno · Lipidica, a.s. · NCT06549725 Early Detection of OAB and Elimination of Negative Impact on Quality of Life
NA · Brno University Hospital · Institute of Health Information and Statistics of the Czech · NCT07371000 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · MUDr Libor Nechvatal sro · Amgen · NCT07037433 A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintena
Phase 3 · Fakultní Nemocnice Brno ( Site 1003) · Merck Sharp & Dohme LLC · NCT07216703 A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine
Phase 3 · Pratia Brno, Merz Investigational Site #4200053 · Merz Therapeutics GmbH · NCT07018700 A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Phase 3 · Vojenska nemocnice Brno · Janssen Research & Development, LLC · NCT07499232 A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Child
Phase 3 · Fakultní nemocnice Brno, Detská nemocnice - Pediatrická klin · Bayer · NCT07192952 A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined
Phase 3 · University Hospital Brno · Regeneron Pharmaceuticals · NCT06091865 A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
Phase 2 · Investigational Site Number: 2030002 · Sanofi · NCT06958536 A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previ
Phase 3 · Fakultní nemocnice Brno Bohunice Klinika nemocí plicních a t · Pfizer · NCT07144280 Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcera
Phase 3 · SurGal Clinic · Eli Lilly and Company · NCT06937086 A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymph
Phase 3 · Fakultni nemocnice Brno · Loxo Oncology, Inc. · NCT05254743 A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants Wit
Phase 3 · Masarykuv onkologicky ustav-Klinika komplexni onkologicke pe · Merck Sharp & Dohme LLC · NCT06077760 A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone
Phase 3 · Local Institution - 0037 · Celgene · NCT05519085 A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
Phase 3 · Neuro Health Centrum · Bristol-Myers Squibb · NCT06976216 SGLT2 Inhibitor TrEatment iN Patients Awaiting cOronary arTery bYpass Surgery to Reduce Post-opErative AF
Phase 3 · St. Anne University Hospital · Region Örebro County · NCT05852704 Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation.
Phase 2/Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT05948943 EP102 Safety and Efficacy in METTL3 Modulation in Advanced Solid Tumors
Phase 1 · Masaryk Memorial Cancer Institute · Epics Therapeutics · NCT07163325 A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-0
Phase 3 · Masarykuv onkologicky ustav ( Site 0903) · Merck Sharp & Dohme LLC · NCT07489495 Ultrasound Evaluation of Hematoma Risk After Needle EMG in Patient on DOAC Therapy
Phase N/A · University Hospital Brno · Masaryk University · NCT07166302 A Phase 2 Trial to Investigate Efficacy and Safety of Vipoglanstat in Women With Endometriosis
Phase 2 · Gynekologie MEDA s.r.o · Gesynta Pharma AB · NCT07260669 Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Phase 3 · Pratia Brno · Eli Lilly and Company · NCT07353931

Look up another city

Look up another condition